Johnson & Johnson, an industry leader known for its global healthcare innovation, unveiled plans to increase its presence in the state of North Carolina through the creation of a 160,000+ square foot manufacturing facility at FUJIFILM’s newly constructed biopharmaceutical manufacturing site at Holly Springs. This $2 billion, decade-long investment will expand production capacity nationwide and is expected to create approximately 120 new positions in the state.
Over the coming months, Johnson & Johnson (J&J) also plans to outline additional advanced manufacturing projects across the United States, alongside enhancements to its existing domestic facilities. J&J investment in North Carolina, along with other initiatives, underscores the Company’s strategy to strengthen U.S. production of advanced medicines and to ensure that the majority of treatments can be developed to meet patient needs.
“Johnson & Johnson has more manufacturing facilities in the U.S. than in any other country, and we continue to strengthen our presence here,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “With the recent signing of the One Big Beautiful Bill Act, we continue to expand our investment in the U.S. to lead the next era of healthcare innovation.”
Earlier this year, J&J investment plan of $55 billion to enhance U.S. manufacturing, research and development, and technology capacity over the next four years was announced.
Construction is also moving forward steadily at the Wilson, North Carolina facility, which will have over 500 employees at full capacity and will create about 5,000 jobs during construction. Apart from infrastructure, Johnson & Johnson also remains committed to research and development spending, especially in key categories including oncology, neuroscience, immunology, cardiovascular disease, and robotic surgery.
FUJIFILM’s Holly Springs biopharmaceutical plant will allow Johnson & Johnson to further enhance its manufacturing capacity in the U.S. Across the country, these strategic investments are expected to generate thousands of jobs.
